Amgen Inc. (AMGN) Stock Analysis

Amgen Inc. (AMGN) Stock Analysis — AI Research | MarketCI

AMGN

Market Closed

Amgen Inc.

NASDAQHealthcare Drug Manufacturers - General

28.00K employees

CEO: Robert A. Bradway

Founded: 1983

$337.60

+$0.00(+NaN%)

Market Cap

182.21B

Beta

0.42

52W Range

N/A

Dividend Yield

2.99%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

AMGN Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for AMGN built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Hold

Pass %

57.14%

Score

4/7

Fair Value Estimate

Cash flow analysis • Multiple methods

$1,068.38

AI Price Target

Machine learning • Price prediction

$333.84

Market Sentiment

News & social media analysis

0.05

Value Investor Price

Classic value analysis

$35.91

Financial Health

Bankruptcy risk assessment

2.31

Quality Score

Financial strength rating

8.00

AI Investment Grade

Deep analysis of filings & news

72.00

Key Investment Highlights

Important factors affecting AMGN investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

63.41% Good

Conditions Met

26.00/41.00

Due Diligence Score

63.41%

Due Diligence Conditions

Investment analysis conditions and results


	Pass
	Fail
	Fail
	Fail
	Pass
	Pass

Showing 1 to 6 of 46 conditions